Pillar Therapeutics, Inc. — Form D

Pillar Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-13. The offering totals $25.0M, of which $14.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-13
• Form: D
• Accession: 0002133041-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $25.0M
• Amount sold: $14.0M
• Remaining: $11.0M
• Investors: 2
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-583919

Issuer

• Name: Pillar Therapeutics, Inc.
• CIK: 0002133041
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116
• Phone: 720-566-4255

Officers, directors & promoters (4)

More

• CIK 2133041 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search